Sodium homeostasis with chronic sodium loading in preascitic cirrhosis

Gut

Volumn 49, Issue 6, 2001, Pages 847-851

  Wong, F ^a   Liu, P ^a   Blendis, L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Preascitic cirrhosis; Renin angiotensin aldosterone system; Sodium handling

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; NEUROHORMONE; NORADRENALIN; RENIN; SODIUM;

ALDOSTERONE BLOOD LEVEL; ARTICLE; ASCITES; BLOOD VOLUME; HEMODYNAMICS; HOMEOSTASIS; LIVER CIRRHOSIS; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT LOADING; SODIUM URINE LEVEL; SYMPATHETIC TONE; WEIGHT GAIN; WEIGHT REDUCTION;

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; BLOOD VOLUME; FEMALE; HOMEOSTASIS; HUMANS; KIDNEY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NOREPINEPHRINE; RENIN; SODIUM; SODIUM, DIETARY; TIME FACTORS; WEIGHT GAIN;

EID: 0035178620     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.49.6.847     Document Type: Article

References (34)

1. Pattern of sodium handling and its consequences in pre-ascitic cirrhosis
2. The response of atrial natriuretic factor and sodium excretion to dietary sodium challenges in patients with chronic liver disease
3. The renal response to a saline load in well compensated alcoholic cirrhosis
4. Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation
5. Central blood volume in cirrhosis: Measurement by radionuclide angiography
6. Renal distal tubular handling of sodium in central fluid volume homeostasis in pre-ascitic cirrhosis
7. Reduced central blood volume in cirrhosis
8. Decreased right heart blood volume determined by magnetic resonance imaging: Evidence of central underfilling in cirrhosis
9. Systemic hemodynamic, forearm vascular, renal and humoral response to sustained cardiopulmonary baroreceptor deactivation in cirrhosis
10. High plasma levels of atrial natriuretic peptide in pre-ascitic cirrhosis: Indirect evidence of reduced natriuretic effectiveness of the peptide
11. High plasma cardiac natriuretic peptides associated with enhanced cyclic guanosine monophosphate production in preascitic cirrhosis
12. Renin and angiotensin mRNA expression in the kidneys of rats subjected to long-term bile duct ligation
13. The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis
14. Studies on the activity of the renin-angiotensin-aldosterone system in patients with cirrhosis of the liver
15. Impaired cardiopulmonary responses to exercise in moderate hypertension
16. Radioimmunoassay of atrial natriuretic factor, human plasma levels
17. Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection
18. Electrochemical detection of catecholamines in urine and plasma after separation with HPLC
19. Bed-rest induced hypernatriuresis in cirrhotic patients without ascites: Does it contribute to maintained compensation?
20. Hepatorenal disorders: Role of the renin-angiotensin aldosterone system
21. Renal sodium retention during upright posture in pre-ascitic cirrhosis
22. Pathophysiology of sodium retention and ascites formation in cirrhosis: Role of atrial natriuretic factor
23. Relationship between plasma ANF responsiveness and renal sodium handling in cirrhotic humans
24. Modulation of the renin-angiotensin system by atrial natriuretic peptide
25. Studies on minerocorticoid escape in cirrhosis
26. Circadian variation in renal sodium and potassium handling in cirrhosis. The role of aldosterone, cortisol, sympathoadrenergic tone and intratubular factors
27. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension
28. Renin-angiotensin-aldosterone system in cirrhosis
29. Is atrial natriuretic factor a physiological regulator of sodium excretion? A review of evidence
30. Cardiovascular and renal effects of low dose atrial natriuretic peptide in compensated cirrhosis
31. Sodium restriction blunts expansion of plasma volume and ameliorates the hyperdynamic circulation in portal hypertension
32. Plasma volume contraction in portal hypertension
33. Effects of low sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis
34. Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites